Epidemic meningitis due to Group A Neisseria meningitidis in the African meningitis belt: a persistent problem with an imminent solution FM LaForce, N Ravenscroft, M Djingarey, S Viviani Vaccine 27, B13-B19, 2009 | 209 | 2009 |
The predominant polyphenol in the leaves of the resurrection plant Myrothamnus flabellifolius, 3,4,5 tri-O-galloylquinic acid, protects membranes against … JP Moore, KL Westall, N Ravenscroft, JM Farrant, GG Lindsey, WF Brandt Biochemical Journal 385 (1), 301-308, 2005 | 140 | 2005 |
Size fractionation of bacterial capsular polysaccharides for their use in conjugate vaccines P Costantino, F Norelli, A Giannozzi, S D'Ascenzi, A Bartoloni, S Kaur, ... Vaccine 17 (9-10), 1251-1263, 1999 | 114 | 1999 |
Bactericidal monoclonal antibodies that define unique meningococcal B polysaccharide epitopes that do not cross-react with human polysialic acid DM Granoff, A Bartoloni, S Ricci, E Gallo, D Rosa, N Ravenscroft, ... The Journal of Immunology 160 (10), 5028-5036, 1998 | 108 | 1998 |
NMR assays for carbohydrate-based vaccines C Jones, N Ravenscroft NMR spectroscopy in pharmaceutical analysis, 341-368, 2008 | 94 | 2008 |
Characterization of mutants of Caulobacter crescentus defective in surface attachment of the paracrystalline surface layer SG Walker, DN Karunaratne, N Ravenscroft, J Smit Journal of bacteriology 176 (20), 6312-6323, 1994 | 91 | 1994 |
Size determination of bacterial capsular oligosaccharides used to prepare conjugate vaccines N Ravenscroft, G Averani, A Bartoloni, S Berti, M Bigio, V Carinci, ... Vaccine 17 (22), 2802-2816, 1999 | 86 | 1999 |
Size determination of bacterial capsular oligosaccharides used to prepare conjugate vaccines against Neisseria meningitidis groups Y and W135 A Bardotti, G Averani, F Berti, S Berti, C Galli, S Giannini, B Fabbri, ... Vaccine 23 (16), 1887-1899, 2005 | 72 | 2005 |
Structural analysis of O-polysaccharide chains extracted from different Salmonella Typhimurium strains F Micoli, N Ravenscroft, P Cescutti, G Stefanetti, S Londero, S Rondini, ... Carbohydrate research 385, 1-8, 2014 | 67 | 2014 |
Purification and characterization of a Shigella conjugate vaccine, produced by glycoengineering Escherichia coli N Ravenscroft, MA Haeuptle, M Kowarik, FS Fernandez, P Carranza, ... Glycobiology 26 (1), 51-62, 2016 | 62 | 2016 |
Development of a new method for the quantitative analysis of the extracellular polysaccharide of Neisseria meningitidis serogroup A by use of high-performance anion-exchange … S Ricci, A Bardotti, S D'Ascenzi, N Ravenscroft Vaccine 19 (15-16), 1989-1997, 2001 | 61 | 2001 |
Characterization, Biosynthesis, and Regulation of Granulose in Clostridium acetobutylicum AL Reysenbach, N Ravenscroft, S Long, DT Jones, DR Woods Applied and environmental microbiology 52 (1), 185-190, 1986 | 61 | 1986 |
Structural analysis of fructans from Agave americana grown in South Africa for spirit production N Ravenscroft, P Cescutti, MA Hearshaw, R Ramsout, R Rizzo, ... Journal of Agricultural and Food Chemistry 57 (10), 3995-4003, 2009 | 54 | 2009 |
Desiccation-induced ultrastructural and biochemical changes in the leaves of the resurrection plant Myrothamnus flabellifolia JP Moore, M Hearshaw, N Ravenscroft, GG Lindsey, JM Farrant, ... Australian Journal of Botany 55 (4), 482-491, 2007 | 49 | 2007 |
Synthesis of structures corresponding to the capsular polysaccharide of Neisseria meningitidis group A R Slättegård, P Teodorovic, HH Kinfe, N Ravenscroft, DW Gammon, ... Organic & Biomolecular Chemistry 3 (20), 3782-3787, 2005 | 48 | 2005 |
Identification, isolation, and structural studies of extracellular polysaccharides produced by Caulobacter crescentus N Ravenscroft, SG Walker, GG Dutton, J Smit Journal of bacteriology 173 (18), 5677-5684, 1991 | 47 | 1991 |
Structure of the sialic acid‐containing O‐specific polysaccharide from Salmonella enterica serovar Toucra O48 lipopolysaccharide A Gamian, C Jones, T Lipiński, A Korzeniowska‐Kowal, N Ravenscroft European Journal of Biochemistry 267 (11), 3160-3167, 2000 | 43 | 2000 |
Quantitative determination of saccharide in Haemophilus influenzae type b glycoconjugate vaccines, alone and in combination with DPT, by use of high-performance anion-exchange … A Bardotti, N Ravenscroft, S Ricci, S D’Ascenzi, V Guarnieri, G Averani, ... Vaccine 18 (19), 1982-1993, 2000 | 42 | 2000 |
Structural analysis of the O-acetylated O-polysaccharide isolated from Salmonella paratyphi A and used for vaccine preparation N Ravenscroft, P Cescutti, M Gavini, G Stefanetti, CA MacLennan, ... Carbohydrate Research 404, 108-116, 2015 | 36 | 2015 |
Physicochemical characterisation of the oligosaccharide component of vaccines. N Ravenscroft, S D'Ascenzi, D Proietti, F Norelli, P Costantino Developments in Biologicals 103, 35-47, 2000 | 36 | 2000 |